Medical Device Patent Infringement
This project was completed by Intensity. Intensity joined Secretariat on February 1, 2023.
Background
A biomedical engineering firm and a medical device company asserted claims of patent infringement against one another. The patented technology at issue related to minimally disruptive spinal surgery devices and procedures.
Our Analysis
Intensity calculated lost profits and reasonable royalty damages stemming from alleged patent infringement. As part of its work, Intensity performed an analysis of economic factors informing on whether lost profits were an appropriate remedy for the respective patent holders, including demand for the patented product, absence of acceptable non-infringing alternatives, and capacity to exploit demand.
As part its analysis of lost profits, Intensity defined the relevant market for the products at issue and determined sales that the patent holder would have made but for the alleged infringement. Intensity calculated usage of the asserted technology and a sales price that would have occurred but for the alleged infringement. Intensity calculated lost profits on lost sales and determined a reasonable royalty for the remaining units.
As part of its analysis of a reasonable royalty, Intensity conducted an evaluation of each of the 15 Georgia-Pacific factors relating to a hypothetical negotiation for a license to the patented technologies. Intensity evaluated a number of license agreements, licensing policies, commercial relationships, bargaining positions, profitability, contribution of the patented technology, convoyed sales, and other factors informing on the outcome of a hypothetical negotiation between the parties. Intensity calculated an economically appropriate royalty base and royalty rate to determine an appropriate reasonable royalty.
Latest Insights
Article | September 16, 2025
Justice for Players and Diarra Damages Claims
In this article, Amran Nawaz and Allan Ingraham along with Ben Cisneros and Sam Kasoulis of Morgan Sports Law discuss the JFP class action. They explore whether similar class actions could be brought by players, agents and/or clubs before the English courts, whether claims could be brought before the Court of Arbitration for Sport (CAS), and how such claims might be quantified.
News | September 16, 2025
Tamika Tremaglio Quoted in The Washington Post on WNBA CBA Negotiations
Managing Director Tamika Tremaglio was featured in The Washington Post discussing the WNBA’s collective bargaining negotiations and the players’ growing leverage to pursue innovative financial models, including equity stakes. She emphasized that today’s athletes better understand their value and may have access to unique alternatives if negotiations do not end the way players want.
Article | September 15, 2025
Public Policy Can Encourage Physicians to Practice in Underserved Areas
In a column for Centre for Economic Policy Research (CEPR), Secretariat Director Stephanie Khoury, Jonathan M. Leganza, and Alex Masucci discuss new evidence that shows the effectiveness of government-designated Primary Care Health Professional Shortage Areas (HPSAs) in attracting physicians to areas of need.
See All Insights
Talk to Our Insightful Experts